In complex diseases, such as cancer and viral infection, multiple signaling pathways or mechanisms are involved. At Alphamab Oncology, we have developed two proprietary technical approaches to provide innovative
solutions to address this growing trend in the development of modern
biotherapeutics.
INNOVATIVE PIPELINE WITH SIGNIFICANT POTENTIAL AND MITIGATED DEVELOPMENT RISK
Leveraging its proprietary technology platforms, Alphamab Oncology has developed an exciting pipeline with clear
differentiation and global competitiveness.
STATE OF ART cGMP MANUFACTURING WITH A SOLID TRACK RECORD
The production of biologics, such as antibody drugs, is a complex, lengthy and costly process. We have established our own cGMP production facilities with strong in house expertise to address the manufacturing issues.